We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Dolomite Corporation Bhd has teamed up with several parties to set up a joint- venture enterprise in China for the production of syringes and other medical devices.
Quest Diagnostics Incorporated, a provider of diagnostic testing, information and services, announced that it has completed the acquisition of Enterix, Inc., the privately held Australian-based company that developed and manufactures the InSure Fecal Immunochemical Test (F.I.T.), an FDA-cleared test for use in screening for colorectal cancer and other sources of lower gastrointestinal bleeding, for approximately $43 million in cash.
Bovie Medical Corporation, a manufacturer and marketer of electrosurgical products, announced that it has received U.S. Food and Drug Administration (FDA) 510(k) clearance to market the ICON GI for gastroenterological procedures.
California authorities are warning at least 850 women that their doctors are being investigated for allegedly illegally obtaining intrauterine devices.
AdvaMed has requested guidance from the Industry Guidance Branch of the Department of Health and Human Services' Office of the Inspector General (OIG) regarding certain physician investment interests in device manufacturers and distributors.
Innogenetics, a maker of diagnostics and therapeutic vaccines, announced Sept. 8 it had been awarded $7 million for "willful" patent infringement by Abbott Laboratories.
As the Japanese regulatory landscape shifts toward shorter approval times, one firm recently emerged from a nine-year process to tell its tale of what it takes to get a device into the Japanese market.
Johnson & Johnson and Boston Scientific, the top makers of drug-coated heart stents, both released studies saying their $2,200 devices are safer than bare-metal stents that cost half as much.
CAS Medical Systems announced that it has received 510(k) clearance from the U.S. Food and Drug Administration (FDA) for expanded use of its FORE-SIGHT Absolute Cerebral Oximeter in additional patient populations including children over 40 kg and infants.